A drug and a DNA variant increase heart disease risk in cancer survivors

Scientists from St. Jude Children's Research Hospital have identified a genetic variant associated with substantially increased risk of heart disease in survivors of childhood cancer treated with the chemotherapy doxorubicin.

Read more: https://medicalxpress.com/news/2022-06-drug-dna-variant-heart-disease.html